Founded in Sweden, Lithea was created to change how solid cancer tumours are treated. We're creating the next generation of cancer therapy, starting with bone cancer.
Chief Executive Officer
Ludvig Sjöberg has over 10 years’ experience in life science across R&D and commercial roles. He was most recently CEO of a medtech company in organ transplantation and has also worked with Igelösa Life Science and Vivoline Medical. He brings expertise in business development, leadership, and cross-sector collaboration. Ludvig holds a B.Sc. in Mechanical and Material Engineering with additional studies in management.
Chairman of the Board, Chief Medical Officer
With over 10 years of international medical experience, Mathias has worked in the UK, Switzerland, and Sweden. He is a board-certified clinical geneticist and has served as a registrar in oncology at Skåne University Hospital and Addenbrooke’s Hospital in Cambridge. He holds a medical degree from the University of Cambridge and a Ph.D. in health economics from Karolinska Institute.
Chief Technical Officer
Deepak conducts ongoing research at Lund University in biomaterials and targeted drug delivery for cancer, infection, and bone healing. He has published widely in scientific journals and received several nominations for the New Investigator Recognition Award from the Orthopedic Research Society. In 2022, he was a finalist among promising entrepreneurs in Southern Sweden. Deepak holds a Ph.D. from the Faculty of Medicine, Lund University.
Director Design & Development
Anna is a skilled R&D professional with broad experience in the medical device and pharmaceutical industry. Before joining Lithea, she was Product and Process Support Manager at the listed company Immunovia AB. She has also held roles at Johnson & Johnson, Baxter International, and Gambro AB, further building her expertise. Anna holds a Ph.D. in Biochemistry from Lund University.
Director Manufacturing & Supply
Linda has over 18 years of experience in R&D, production, and product development. Before joining Lithea, she held key roles at listed companies including Genovis AB and GE Healthcare. As former Vice President Production, she led production and quality control teams while contributing to product development. Linda holds an M.Sc. in Chemistry from Lund University.
Chairman of the Board, Chief Medical Officer
With over 10 years of international medical experience, Mathias has worked in the UK, Switzerland, and Sweden. He is a board-certified clinical geneticist and has served as a registrar in oncology at Skåne University Hospital and Addenbrooke’s Hospital in Cambridge. He holds a medical degree from the University of Cambridge and a Ph.D. in health economics from Karolinska Institute.
Board member
Kristina Tägil, MD, PhD, has been working for 20 years at the interface between healthcare and technology and during the years founded several companies in the digital health sector. The refinement of healthcare using the new technology has been the beacon in her career and has continued to contribute by acting as an advisor and mentor for start-up companies. Kristina currently works as a Lead Physician Executive at Cerner AB, a global company that develops digital ecosystems in healthcare.
Board member